Company Analysis
Sign in

NRX Pharmaceuticals, Inc. (NRXP)

Nasdaq: NRXP · Pharmaceutical Preparations · Wilmington, DE · filing with the SEC since 2017
Full chart Alerts Compare
Grade2.8
◀ Past 3.7● Present 1.7▶ Future 3.2
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Report filedMar 23, 2026Mar 14, 2025Mar 29, 2024Mar 31, 2023Mar 31, 2022Apr 1, 2021Mar 30, 2020Mar 15, 2019Mar 23, 2018
Revenue1,445,00000······
For lenders
Net interest income·····138,7641,205,8201,088,915·
Cost of revenue505,0000·······
Research and development3,777,0006,199,00013,371,00017,027,00020,257,00010,625,000···
Selling, general and administrative13,061,00013,500,000·······
General and administrative·13,505,00014,216,00027,308,00074,944,00011,436,000···
Total operating expenses·18,502,00027,837,00044,335,000115,796,00051,387,000r713,1871,006,503·
Total costs and expenses17,449,00018,502,000·······
Operating income-16,224,000-18,502,000-27,837,000-44,335,000-115,796,000-51,387,000r-713,187-1,006,503·
Interest expense671,000230,000120,000·18,00056,000···
Interest and investment income12,00044,000494,000249,000·····
Share of profit of equity-method investments-35,0000·······
Total non-operating income (expense)-12,398,000-6,624,000-2,313,0004,581,00022,733,000-390,000r1,205,8201,088,915·
Income before income taxes···-39,754,000-93,063,000-51,777,000r492,63382,412·
Income tax expense000··17,84184,20616,311·
Net income including non-controlling interests··-30,150,000-39,754,000-93,063,000····
Net income-28,622,000-25,126,000-30,150,000-39,754,000-93,063,000-51,777,000r408,42766,101·
Net income to common shareholders·-25,126,000-30,159,000-39,754,000-348,885,000-51,777,000-295,467-748,864·
Earnings per share, basic-1.34-2.36-3.98r-6.00b-19.80b-15.10b···
Earnings per share, diluted···-6.00b-19.80b-15.10b···
Earnings per share, basic and diluted······-1.10b-2.90b·
Weighted average shares, basic21,401,68310,644,4617,576,176r6,576,679b4,691,770b3,427,096b···
Weighted average shares, diluted···6,576,679b4,691,770b3,427,096b···
Weighted average shares, basic and diluted······278,302b261,450b·
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-10 reverse split of Mar 2024.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Net interest income interest earned less interest paidus-gaap:InterestIncomeExpenseNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
us-gaap:InterestIncomeOther
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton NRXP · research, not advice